 | Up a level |
Koziolek, M., Beige, J., Wallbach, M., Zenker, D., Henning, G., Halbach, M., Mader, N., Mahfoud, F., Schlieper, G., Schwenger, V., Hausberg, M., Boergel, J., Lodde, M., van der Giet, M., Mueller-Ehmsen, J., Passauer, J., Parmentier, S., Lueders, S., Kraemer, B. K., Buettner, S., Limbourg, F., Jordan, J., Vonend, O., Predel, H. -G. and Reuter, H. (2017). Baroreceptor activation therapy for therapy-resistant hypertension: indications and patient selection. Recommendations of the BAT consensus group 2017. Internist, 58 (10). S. 1114 - 1124. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1289
Wachter, R., Halbach, M., Bakris, G., Bisognano, J., Haller, H., Beige, J., Kroon, A. A., Nadim, M., Lovett, E., Schafer, J. and de Leeuw, P. W. (2016). SAFETY AND BLOOD PRESSURE EFFECTS OF SECOND-VERSUS FIRST-GENERATION SYSTEM FOR ADMINISTERING BAROREFLEX ACTIVATION THERAPY. J. Hypertens., 34. S. E94 - 1. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1473-5598